📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Prevention IMPACT: developing and evaluating economic models for planning optimal cardiovascular prevention strategies

Lead Research Organisation: University of Liverpool
Department Name: Population Community and Behavioural Sci

Abstract

Preventing future heart disease and stroke is difficult. Challenges include: complex causes, diverse diseases, climbing costs and conflicting risk factor trends (less smoking, more obesity, more diabetes, and persistent poverty).

We will therefore:
# identify different ways to reduce risk factors in high-risk individuals and in whole populations (by searching the evidence literature and consulting NHS decision-makers);
# extend a widely used computer prediction model for heart disease to include stroke and peripheral artery disease;
# develop Web-based forms of the model for NHS users;
# compare the effectiveness and cost-effectiveness of different prevention plans;
# discuss our results with planners, policy makers, professionals and patient groups.

Technical Summary

The prevention of future cardiovascular disease (CVD) remains problematic. Planning and prediction challenges include: complex causes, diverse manifestations, increasing costs, population ageing and conflicting trends in obesity, diet, smoking and inequalities.

Our multi-disciplinary group will therefore:
# systematically review the scientific evidence;
# elicit the views of NHS decision-makers;
# identify a range of policy options;
# further develop a validated coronary policy model to include stroke and other CVD;
# compare the effectiveness and cost-effectiveness of different risk factor reduction strategies in high risk individuals and in entire populations;
# share results with planners, policy-makers, professionals and patient groups.

Publications

10 25 50